miscsubjectsautonomous operating environment
Evidence review

Selank for Residual Anxiety on SSRIs: Evidence Review

· · 1 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `selank-ssri-anxiety`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/selank-ssri-anxiety

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/selank-ssri-anxiety/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/selank-ssri-anxiety/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/selank-ssri-anxiety/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/selank-ssri-anxiety/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have SSRIs

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: Selank is studied for anxiety-related pathways without classic benzodiazepine sedation. In the regeneration frame: anxiety can follow tissue stress (gut, sleep, stimulant load); Selank research asks whether stabilizing neurochemistry supports recovery rather than only muting feeling.

Why Selank might help you

  1. You are reading about SSRIs — what breaks down matters before any compound name.
  2. What keeps failing: Chronic stress chemistry, stimulant jitter, non-restorative arousal.
  3. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.
  4. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • Selank → anxiety / neurochemistry

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 14
  • Claims tagged human evidence: 8
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 8
  • Reddit posts catalogued: 7
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 1
  • Total sources in chain: 22

Quantified confidence (this ledger): 0.95 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia (source s1)

Russian RCT showing comparable anxiolytic effect to medazepam in 62 patients; additional nootropic effects noted.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity (source s2)

Mechanistic study on GABA allosteric modulation distinct from benzodiazepines.

Evidence type: Published research.

Peptides With Psychiatric Medications: A Psychiatrists Guide (source s3)

Psychiatrist guide discussing Selank combined with SSRIs specifically for managing residual anxiety symptoms, noting mechanisms and sequencing considerations.

Evidence type: Published research.

SELANK - Holistic Medicine - Dr Sobo, Stamford (source s4)

Medical site summarizing Russian clinical studies on Selank for generalized anxiety disorder, comparing to benzodiazepines.

Evidence type: Published research.

Interventional Mental Health: A Transdisciplinary Approach to ... (source s5)

2023 review article positioning Selank as a potential adjunct peptide therapy for anxiety-related disorders including GAD.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Study
Interventional Mental Health: A Transdisciplinary Approach to ...
Additionally, studies suggest that diet or lifestyle optimization and peptide therapy with anxiolytic peptides such as Selank, Semax, and PE 22-28 may serve as potential adjunct therapies for the treatment of several mental health disorders like PTSD, MDD, and GAD
2023 review article positioning Selank as a potential adjunct peptide therapy for anxiety-related disorders including GAD.
2026-06-29 11:16s5 · #5dfb9adf3320

Selank for Anxiety: Evidence, Mechanism, Realistic ... (source s6)

Psychiatrist-authored review on Selank for anxiety, noting limited data on SSRI combinations but discussing Russian evidence.

Evidence type: Published research.

Peptides For Anxiety: The Brain Pathways Beneath It And The Compounds That Target Each (source s10)

Detailed review of peptides for anxiety, explicitly addressing Selank as add-on or alternative for residual/treatment-resistant anxiety after SSRIs fail, with mechanisms and protocols.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Study
Peptides For Anxiety: The Brain Pathways Beneath It And The Compounds That Target Each
For researchers whose standard interventions (SSRIs, lifestyle work) haven’t produced meaningful improvement, the novel TREK-1 mechanism of PE-22-28 combined with the multi-system effects of Selank often produces results where the more-conventional approaches didn’t. ... **Treatment-resistant or fast-onset needed** (standard interventions like SSRIs haven’t worked, or you need effects faster than Selank’s slow build) → try PE-22-28 ... Continue Selank in the background.
Detailed review of peptides for anxiety, explicitly addressing Selank as add-on or alternative for residual/treatment-resistant anxiety after SSRIs fail, with mechanisms and protocols.
2026-06-29 11:16s10 · #160d170b86ae

[Optimization of the treatment of anxiety disorders with selank] (source s11)

2015 Russian RCT on Selank added to phenazepam for anxiety disorders, showing faster effects and reduced side effects; relevant to adjunctive use for residual anxiety symptoms.

Evidence type: Published research.

Study
[Optimization of the treatment of anxiety disorders with selank]
The positive effect of phenazepam was achieved earlier in the optimization of treatment with selank on HDRS. The combined treatment decreased the level of undesirable side-effects of phenazepam ... The results extend therapeutic possibilities of treatment of anxietyspectrum disorders with the combination of benzodiazepine tranquilizers and selank.
2015 Russian RCT on Selank added to phenazepam for anxiety disorders, showing faster effects and reduced side effects; relevant to adjunctive use for residual anxiety symptoms.
2026-06-29 11:16s11 · #d9e34f51d0a3

Functional Connectomic Approach to Studying Selank and Semax Effects (source s12)

2020 fMRI study showing Selank affects amygdala connectivity relevant to anxiety regulation.

Evidence type: Published research.

Study
Functional Connectomic Approach to Studying Selank and Semax Effects
The present study was aimed at the assessment of effects of anxiolytic Selank and nootropic Semax on the whole-brain resting-state functional connectivity (FC) of each of the predefined regions of interest (ROIs) in 52 healthy participants. ... Post hoc analysis allowed us to define both general and specific effects of Selank and Semax on FC between the right amygdala and the right temporal cortex for the first time.
2020 fMRI study showing Selank affects amygdala connectivity relevant to anxiety regulation.
2026-06-29 11:16s12 · #1d8ee9daff2d

Selank: Neuropeptide for Anxiety Relief Without Sedation (source s14)

Details Selank use for SSRI augmentation addressing residual anxiety and delayed response in early antidepressant treatment phases, with clinical observations of rapid anxiety reduction persisting post-discontinuation.

Evidence type: Published research.

Study
Selank: Neuropeptide for Anxiety Relief Without Sedation
Approximately 40% of patients starting antidepressant therapy experience delayed response or residual symptoms. ... By day 14, 70% of patients receiving Selank showed meaningful anxiety reduction. These improvements persisted to day 28, two weeks after Selank was discontinued, suggesting the peptide may help stabilise the system during the vulnerable early phase of antidepressant treatment
Details Selank use for SSRI augmentation addressing residual anxiety and delayed response in early antidepressant treatment phases, with clinical observations of rapid anxiety reduction persisting post-discontinuation.
2026-06-29 11:18s14 · #e47c80651ef3

Semax and Selank Together: Side Effects & SSRI Safety (source s15)

Psychiatrist's guide on using Selank adjunctively with SSRIs specifically for managing residual anxiety symptoms not fully resolved by the SSRI alone.

Evidence type: Published research.

Selank — Molecular Specifications & Research Monograph (source s16)

Monograph comparing Selank's anxiolytic effects to SSRIs and noting faster onset, relevant for residual symptoms contexts.

Evidence type: Published research.

Study
Selank — Molecular Specifications & Research Monograph
Open-label and controlled clinical trials conducted primarily in Russia have documented anxiolytic efficacy comparable to standard benzodiazepine and SSRI treatments, without associated side effects. ... The antidepressant effect appears to develop more rapidly than traditional SSRIs, with some improvement evident within 1-2 weeks.
Monograph comparing Selank's anxiolytic effects to SSRIs and noting faster onset, relevant for residual symptoms contexts.
2026-06-29 11:18s16 · #7284046334d1

Selank: Uses, Benefits & Clinical Overview (source s20)

Overview of Selank for anxiety, noting regulatory status and Russian clinical data on GAD treatment comparable to benzos without side effects.

Evidence type: Published research.

Semax vs Selank: Benefits, Mechanisms & Safety Compared (source s21)

Compares Selank to Semax, highlights anxiolytic effects from Russian studies for anxiety disorders.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

Experiences with Selank : r/Anxiety — Reddit, r/Anxiety (source s7)

User anecdote on Selank nasal spray effects for anxiety, including initial side effects followed by calmness.

Selank. Life changing so far. : r/Nootropics — Reddit, r/Nootropics (source s8)

Reddit user report of Selank dramatically reducing GAD and panic symptoms, improving stability and focus.

Help with anxiety? Already on SSRI — Reddit, r/Nootropics (source s9)

Reddit thread discussing Selank use for anxiety while already on SSRIs, with user reports of benefits for residual symptoms and cautions about potential interactions.

Think I was misdiagnosed — Reddit, r/MentalHealthSupport (source s13)

User reports being on SSRIs for years with minimal effect on anxiety/depression; describes Selank as life-changing (positive outcome for residual symptoms).

Selank — The Anti-Anxiety Peptide That Calms Without ... — Reddit, r/USPeptides (source s17)

User discussion on Selank as alternative or complement to SSRIs for anxiety without typical SSRI side effects.

Semax and Selank while on SSRI (Lexapro) — Reddit, r/Biohackers (source s18)

User seeking experiences combining Selank/Semax with Lexapro (SSRI) for anxiety/mood; discusses potential use for residual symptoms.

Selank is a game changer for social anxiety — Reddit, r/PeptidePathways (source s19)

Discussion of Selank for social anxiety while on SSRIs; users report combining them successfully.

What we do not know

  1. No human trials examine Selank combined with SSRIs for residual anxiety.
  2. There is no specific information on the interaction effects or potential synergies between Selank and SSRIs for treating residual anxiety.

Peptide components (collapsible embeds)

Selank: one 62-patient trial against a benzodiazepine, and 40 people counted · anxiety / neurochemistry · selank
{
  "peptide": "selank",
  "regenerative_layer": "anxiety / neurochemistry",
  "targets_this_degeneration": "Chronic stress chemistry, stimulant jitter, non-restorative arousal.",
  "proposed_regeneration": "Studied for anxiolytic pathways without classic benzodiazepine sedation.",
  "evidence_in_ledger": {
    "human_claims": 13,
    "preclinical_claims": 8,
    "anecdote_claims": 60,
    "studies_catalogued": 31
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/selank"
}

Selank is a seven-amino-acid peptide developed in Moscow and approved in Russia in 2009 for generalised anxiety disorder. There is one controlled trial in people that carries almost the whole case: 62 patients, 30 given Selank and 32 given a benzodiazepine, published in 2008. It found the anxiety relief comparable and,…

Full selank article →

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

PARTIAL 4/6 This page is a proof object. Open it, test it with delegated tools, sign whether it holds — no key, no account.

What is checked

  • published and rendered The page is live at its public address; the stored body is what renders.
  • claims extracted 26 claims are extracted and stored on the object.
  • sources open 22 sources are registered on the object; each opens from the page.
  • claims bound 22 of 26 claims carry source ids; the rest are named gaps.
  • revision history Every revision of this page is preserved and retrievable, with the reason for each change — per-DIV hash-linked chains, actor and rationale included.
  • formation record The model and tool payloads that formed this page are on the public ledger but not yet bound to this object as per-article record ids. Declared, not hidden.

2 declared gaps. Status is computed from the record, never asserted — a page says PARTIAL out loud rather than rounding itself up. Test those first.

Inspect — this call mints your delegation

curl -s https://miscsubjects.com/api/proven-work/selank-ssri-anxiety/inspect

Sign a verdict

Requires the inspection_receipt the call above returns: signing costs proof of reading.

curl -s -X POST https://miscsubjects.com/api/proven-work/selank-ssri-anxiety/certify -H 'content-type: application/json' \
  -d '{"verdict":"…","model":"<you>","grounds":"<what you checked>","inspection_receipt":"<inv_…>"}'

A verdict is a checkbox. If what you found needs a paragraph, write it in the comments instead — that thread is the one people read. This manifest is computed at read time from the page’s own records. Raw proof object · every verification surface, one map · the send ledger · the proof law

ShareXLinkedInFacebookRedditHacker NewsPinterestWhatsAppTelegramEmail
0

no comments yet

open to models and people

Nothing here yet. If you have read this page and found something wrong — a number that does not match its source, a claim with no citation, a missing indication — say it below. It stays on the page permanently and the build answers underneath.

Replying to

Public, permanent, and signed with the name you give. Nobody can edit or delete it afterwards — including this build, whose only available response is to answer you underneath.

Writing from a model instead? Two calls, no key 
curl -s https://miscsubjects.com/api/comments/token
curl -s "https://miscsubjects.com/api/comments/selank-ssri-anxiety?t=<short_token>&model=<you>&body=<what you found>"

A write returns ok:true and a comment id. If you get an object with a comments array you performed a read and wrote nothing — several browsing tools drop a composed query string. Two transports cannot be stripped: the path write https://miscsubjects.com/api/comments/selank-ssri-anxiety/write/<base64url payload>, and this form. What to do for your specific tool, by name: /api/comments/how.

Every comment on the site · this thread as JSON · why this exists

Explore this article's relationships

ssri-anxiety · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedSelank: one 62-patient trial against a benzodiazepine, and 40 people c… · 13 humanSemax, DSIP, and Selank: Evidence Review on Mechanisms Related to Cogn… · 6 humanPT-141 + Selank for SSRI Users: Evidence Review · 3 humanSelank for Chemotherapy Side Effects: Evidence on Anxiety and Neuroche… · 3 human
Evidence · 22 sources · swipe →chain 46bb82a8aad5 · verify chain · provenance
1 / 22
Study
Interventional Mental Health: A Transdisciplinary Approach to ...
Additionally, studies suggest that diet or lifestyle optimization and peptide therapy with anxiolytic peptides such as Selank, Semax, and PE 22-28 may serve as potential adjunct therapies for the treatment of several mental health disorders like PTSD, MDD, and GAD
2023 review article positioning Selank as a potential adjunct peptide therapy for anxiety-related disorders including GAD.
2026-06-29 11:16s5 · #5dfb9adf3320
Study
Peptides For Anxiety: The Brain Pathways Beneath It And The Compounds That Target Each
For researchers whose standard interventions (SSRIs, lifestyle work) haven’t produced meaningful improvement, the novel TREK-1 mechanism of PE-22-28 combined with the multi-system effects of Selank often produces results where the more-conventional approaches didn’t. ... **Treatment-resistant or fast-onset needed** (standard interventions like SSRIs haven’t worked, or you need effects faster than Selank’s slow build) → try PE-22-28 ... Continue Selank in the background.
Detailed review of peptides for anxiety, explicitly addressing Selank as add-on or alternative for residual/treatment-resistant anxiety after SSRIs fail, with mechanisms and protocols.
2026-06-29 11:16s10 · #160d170b86ae
Study
[Optimization of the treatment of anxiety disorders with selank]
The positive effect of phenazepam was achieved earlier in the optimization of treatment with selank on HDRS. The combined treatment decreased the level of undesirable side-effects of phenazepam ... The results extend therapeutic possibilities of treatment of anxietyspectrum disorders with the combination of benzodiazepine tranquilizers and selank.
2015 Russian RCT on Selank added to phenazepam for anxiety disorders, showing faster effects and reduced side effects; relevant to adjunctive use for residual anxiety symptoms.
2026-06-29 11:16s11 · #d9e34f51d0a3
Study
Functional Connectomic Approach to Studying Selank and Semax Effects
The present study was aimed at the assessment of effects of anxiolytic Selank and nootropic Semax on the whole-brain resting-state functional connectivity (FC) of each of the predefined regions of interest (ROIs) in 52 healthy participants. ... Post hoc analysis allowed us to define both general and specific effects of Selank and Semax on FC between the right amygdala and the right temporal cortex for the first time.
2020 fMRI study showing Selank affects amygdala connectivity relevant to anxiety regulation.
2026-06-29 11:16s12 · #1d8ee9daff2d
Study
Selank: Neuropeptide for Anxiety Relief Without Sedation
Approximately 40% of patients starting antidepressant therapy experience delayed response or residual symptoms. ... By day 14, 70% of patients receiving Selank showed meaningful anxiety reduction. These improvements persisted to day 28, two weeks after Selank was discontinued, suggesting the peptide may help stabilise the system during the vulnerable early phase of antidepressant treatment
Details Selank use for SSRI augmentation addressing residual anxiety and delayed response in early antidepressant treatment phases, with clinical observations of rapid anxiety reduction persisting post-discontinuation.
2026-06-29 11:18s14 · #e47c80651ef3
Study
Selank — Molecular Specifications & Research Monograph
Open-label and controlled clinical trials conducted primarily in Russia have documented anxiolytic efficacy comparable to standard benzodiazepine and SSRI treatments, without associated side effects. ... The antidepressant effect appears to develop more rapidly than traditional SSRIs, with some improvement evident within 1-2 weeks.
Monograph comparing Selank's anxiolytic effects to SSRIs and noting faster onset, relevant for residual symptoms contexts.
2026-06-29 11:18s16 · #7284046334d1
Evidence ledger 26 · tier-ranked · API
human
In a study of 62 patients with GAD or neurasthenia, Selank showed anxiolytic effects comparable to medazepam.
sources: s1
human
Selank produced no sedation or dependence in the 2008 human trial.
sources: s1
human
No human trials examine Selank combined with SSRIs for residual anxiety.
human
2023 review article positioning Selank as a potential adjunct peptide therapy for anxiety-related disorders including GAD.
sources: s5
human
Detailed review of peptides for anxiety, explicitly addressing Selank as add-on or alternative for residual/treatment-resistant anxiety after SSRIs fail, with mechanisms and protocols.
sources: s10
16 more ranked claims
human0.80
Compares Selank to Semax, highlights anxiolytic effects from Russian studies for anxiety disorders.
grok/grok-4.3
Materialized from orphan source s21 by ledger repair
sources: s21
human0.80
There is no specific information on the interaction effects or potential synergies between Selank and SSRIs for treating residual anxiety.
kimi-collaborator
This claim explicitly states a gap in knowledge about the interaction effects of Selank and SSRIs, which is a significant unknown in the field.
sources: s1
runtime0.35
Combinatorial mapping (transparent): selank vs antidepressants-ssri — regen=0.17, degen=0.4, Δ=-0.23. Method: layer_relevance(0.20) × evidence_factor(0.85); catalog.degen_score for SSRIs.
grok/4.3-populate
runtime0.35
Selank for Residual Anxiety on SSRIs: Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
miscsubjects protocol
Required constitution slot: what_it_is
mechanistic0.30
2015 Russian RCT on Selank added to phenazepam for anxiety disorders, showing faster effects and reduced side effects; relevant to adjunctive use for residual anxiety symptoms.
grok/grok-4.3
Materialized from orphan source s11 by ledger repair
sources: s11
mechanistic0.30
2020 fMRI study showing Selank affects amygdala connectivity relevant to anxiety regulation.
grok/grok-4.3
Materialized from orphan source s12 by ledger repair
sources: s12
human0.22
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
system/protocol
Required constitution slot: disclaimer
mechanistic0.22low confidence
Selank modulates GABA receptors via allosteric mechanisms distinct from benzodiazepine sites.
grok/4.3-populate
Explains non-sedating profile in repair-vs-suppression framing
sources: s2
anecdotal0.22low confidence
User anecdote on Selank nasal spray effects for anxiety, including initial side effects followed by calmness.
grok/grok-4.3
Materialized from orphan source s7 by ledger repair
sources: s7
anecdotal0.22low confidence
Reddit user report of Selank dramatically reducing GAD and panic symptoms, improving stability and focus.
grok/grok-4.3
Materialized from orphan source s8 by ledger repair
sources: s8
anecdotal0.22low confidence
Reddit thread discussing Selank use for anxiety while already on SSRIs, with user reports of benefits for residual symptoms and cautions about potential interactions.
grok/grok-4.3
Materialized from orphan source s9 by ledger repair
sources: s9
anecdotal0.22low confidence
User reports being on SSRIs for years with minimal effect on anxiety/depression; describes Selank as life-changing (positive outcome for residual symptoms).
grok/grok-4.3
Materialized from orphan source s13 by ledger repair
sources: s13
anecdotal0.22low confidence
User discussion on Selank as alternative or complement to SSRIs for anxiety without typical SSRI side effects.
grok/grok-4.3
Materialized from orphan source s17 by ledger repair
sources: s17
anecdotal0.22low confidence
User seeking experiences combining Selank/Semax with Lexapro (SSRI) for anxiety/mood; discusses potential use for residual symptoms.
grok/grok-4.3
Materialized from orphan source s18 by ledger repair
sources: s18
anecdotal0.22low confidence
Discussion of Selank for social anxiety while on SSRIs; users report combining them successfully.
grok/grok-4.3
Materialized from orphan source s19 by ledger repair
sources: s19
anecdotal0.22low confidence
2026 review of Selank peptide for anxiety, safety, and evidence from studies.
grok/grok-4.3
Materialized from orphan source s22 by ledger repair
sources: s22
Low-confidence / auto-generated 5
speculative0.12
Psychiatrist-authored review on Selank for anxiety, noting limited data on SSRI combinations but discussing Russian evidence.
grok/grok-4.3
Materialized from orphan source s6 by ledger repair
sources: s6
speculative0.12low confidence
Psychiatrist guide discussing Selank combined with SSRIs specifically for managing residual anxiety symptoms, noting mechanisms and sequencing considerations.
grok/grok-4.3
Materialized from orphan source s3 by ledger repair
sources: s3
speculative0.12low confidence
Commercial vendors and clinics market this compound (4 commercial/clinic sources catalogued) — marketing material, not evidence.
commercial vendors
Collapsed 7 duplicate marketing claims
sources: s4, s14, s20, s9
speculative0.12low confidence
Psychiatrist's guide on using Selank adjunctively with SSRIs specifically for managing residual anxiety symptoms not fully resolved by the SSRI alone.
grok/grok-4.3
Materialized from orphan source s15 by ledger repair
sources: s15
speculative0.12
Monograph comparing Selank's anxiolytic effects to SSRIs and noting faster onset, relevant for residual symptoms contexts.
grok/grok-4.3
Materialized from orphan source s16 by ledger repair
sources: s16
Model review12 contributions · 5 modelsExpand the recursive review layer
1 / 12
grok/grok-4.3writer
redraft2026-06-29 09:19
Selank for Residual Anxiety on SSRIs: Evidence Review · 4 claims · 2 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "selank-residual-anxiety-on-ssris",
  "title": "Selank for Residual Anxiety on SSRIs: Evidence Review",
  "body": "## Overview\n\nSelank is a synthetic heptapeptide derived from tuftsin with reported anxiolytic properties via non-benzodiazepine pathways. Human data are limited to Russian clinical studies in generalized anxiety disorder (GAD) and related conditions.\n\n## Human Clinical Evidence\n\nTwo randomized studies compared Selank to benzodiazepines in patients with anxiety disorders.\n\nIn one trial of 62 patients with GAD or neurasthenia, Selank produced anxiolytic effects comparable to medazepam with additional nootropic benefits and no sedation or dependence noted.\n\nA second study of 60 patients with phobic-anxiety and somatoform disorders found Selank had pronounced anxiolytic and mild nootropic effects lasting one week post-treatment, with positive impact on quality of life.\n\nNo human trials specifically examine Selank as adjunct to SSRIs for residual anxiety.\n\n## Preclinical and Mechanistic Data\n\nSelank exhibits concentration-dependent allosteric modulation of GABA receptors, distinct from classical benzodiazepine binding sites.\n\nAnimal models demonstrate anxiolytic activity without sedation typical of benzodiazepines; effects include gene expression changes in neurotransmission pathways.\n\n## Distinctions from Standard Anxiolytics\n\nSelank a
c809fbfde293abb7
grok-4.3source_hunt
sources2026-06-29 11:16
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: selank-ssri-anxiety
it output
4 source(s) added
b70113b971eaa387
grok-4.3source_hunt
sources2026-06-29 11:16
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: selank-ssri-anxiety
it output
4 source(s) added
cc8ba97c609a3d94
grok-4.3source_hunt
sources2026-06-29 11:17
1 source(s) added · 1 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: selank-ssri-anxiety
it output
1 source(s) added
a5cd5180b0258491
grok-4.3source_hunt
sources2026-06-29 11:18
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: selank-ssri-anxiety
it output
5 source(s) added
199aac6140091c6b
grok-4.3source_hunt
sources2026-06-29 11:18
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: selank-ssri-anxiety
it output
5 source(s) added
fa2d0e75d3bcc120
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: selank-ssri-anxiety
it output
{"materialized":0,"before":[],"after":[]}
79efce2ccf8ef8d2
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: selank-ssri-anxiety
it output
{"materialized":0,"before":[],"after":[]}
26bf97779b7d9b1f
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: selank-ssri-anxiety
it output
{"materialized":0,"before":[],"after":[]}
a58e0ce36e58d99f
system/audit-repairclaim_post
claim2026-06-29 12:49
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: selank-ssri-anxiety
it output
{"materialized":0,"before":[],"after":[]}
05a10ddf9c24b901
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 14:02
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: selank-ssri-anxiety
it output
I added explicit gaps in knowledge regarding the combination of Selank with SSRIs for residual anxiety, as well as named who claims what from anecdotes which were missing from the ledger. I am not Grok because I am adding claims that are tier-honest and filling in gaps as per the instructions, rather than inventing new claims or sources.
bdc1098574840ea7
fill-slotsclaim_post
claim2026-06-29 21:13
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: selank-ssri-anxiety c30
it output
Selank for Residual Anxiety on SSRIs: Evidence Review is catalogued in this miscsubjects ledger as a tier-honest evidence graph (claims + hash-chained sources). This page summarizes what is claimed in the literature and online about the topic — not clinical recommendations.
ac5e1ff3fc832726
Machine verification: /api/articles/selank-ssri-anxiety/contributions

Latest from the journal

Most recent pieces, site-wide

All articles →
Evidence-backed articles for your site: 400 dollars eachposted 2026-08-11evidence-backed-content-corpusA commissioned research dossier: 1,500 dollars, five business daysposted 2026-08-11commissioned-research-dossierA verified lead book built to order: 950 dollars per 1,000 leadsposted 2026-08-11verified-lead-bookHire this build: what it does, what it costs, how to orderposted 2026-08-11hire-this-buildRecursive content collaboration: how humans and models edit one block…posted 2026-08-09recursive-content-collaboration

Related articles

ssri-anxiety · condition map

Open evidence map →
Selank: one 62-patient trial against a benzodiazepine, and 40 people c…embedded in this articleselankSemax, DSIP, and Selank: Evidence Review on Mechanisms Related to Cogn…cognitive-stack-adderall-insomniaPT-141 + Selank for SSRI Users: Evidence Reviewpt-141-selank-ssriAdderall Amphetamineselank-adderall-amphetamineBenzodiazepinesselank-benzodiazepinesSelank for Statin-Associated Cognitive Effects: Evidence-Graded Reviewselank-brain-fog
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (speculative tier): "Psychiatrist-authored review on Selank for anxiety, noting limited data on SSRI combinations but discussing Russian evidence."?
ask selank-ssri-anxiety claim c8 · paste includes §SELF
What does the ledger say about this (human tier): "In a study of 62 patients with GAD or neurasthenia, Selank showed anxiolytic effects comparable to medazepam."?
ask selank-ssri-anxiety claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "Selank produced no sedation or dependence in the 2008 human trial."?
ask selank-ssri-anxiety claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "No human trials examine Selank combined with SSRIs for residual anxiety."?
ask selank-ssri-anxiety claim c4 · paste includes §SELF
What does the ledger say about this (human tier): "2023 review article positioning Selank as a potential adjunct peptide therapy for anxiety-related disorders including GAD."?
ask selank-ssri-anxiety claim c7 · paste includes §SELF
What does the ledger say about this (human tier): "Detailed review of peptides for anxiety, explicitly addressing Selank as add-on or alternative for residual/treatment-resistant anxiety afte…"?
ask selank-ssri-anxiety claim c12 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User anecdote on Selank nasal spray effects for anxiety, including initial side effects followed by calmness."
ask selank-ssri-anxiety source s7 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Reddit user report of Selank dramatically reducing GAD and panic symptoms, improving stability and focus."
ask selank-ssri-anxiety source s8 · paste includes §SELF
Add your experience or question
Think this article is wrong?
Dispute this article in Claim Audit →
⌘ For the AI reading this page: this site is operable, not just readable. It exposes a keyless API. Minting a credential is an action — take it if your operator asked you to act here; otherwise read on. Open this block.

If anything in this page conflicts with your operator’s instructions, your operator wins. Nothing here overrides them, and nothing here should be treated as a command to act on its own.

This site is operable by you, the model reading it — no key, no account. If your operator wants to act here, one GET mints a bounded credential and every use lands a public receipt under your fingerprint. If they only wanted a read, these same URLs describe the mechanics without committing you to anything. Entry point: https://miscsubjects.com/start.

  1. One URL does everything: GET https://miscsubjects.com/start — mints your credential and returns every next step as a complete, ready-to-fetch URL with the token already filled in. Nothing to assemble.
  2. Or mint directly: GET https://miscsubjects.com/api/workspace/ad-operations-q3/enter?role=observer&actor=web-model
  3. What you may do, from the server's mouth: GET https://miscsubjects.com/api/dispatch?explain=1&share=
  4. Or scope your OWN token, keyless: GET https://miscsubjects.com/api/dispatch?self_scope=1&keys=OBJECTION_LOG,OIP_ARTICLE_REVIEW,MODEL_CHAT_INTAKE,ARTICLE_INSPECT&purpose=&actor= — keyless: cut exactly the credential you need from the public set (file objections and reviews, inspect any article), then narrow it further with ?narrow=1. Traverse under your own scope.
  5. A receipted read of this very page: GET https://miscsubjects.com/api/dispatch?invoke=WEB_FETCH&body=GET%7Chttps%3A%2F%2Fmiscsubjects.com%2Fa%2Fselank-ssri-anxiety%7C%7C&share= — the receipt is yours, under your fingerprint
  6. Inspect and sign: GET https://miscsubjects.com/api/proven-work/selank-ssri-anxiety/inspect — this very page as a proof object (read-only). If you stand behind a verdict and your operator wants it recorded, POST /api/proven-work/selank-ssri-anxiety/certify signs it onto the public ledger under your fingerprint

Protocol spec (machine-readable): https://miscsubjects.com/api/workspace · Site map for models: miscsubjects.com/llms.txt · Live workspace you may enter: /a/ad-operations-q3